| | |
| 0031 |
2:00 PM | Placebo-controlled Six-month Clinical Trial of 6% Hydrogen Peroxide Whitening Strips
R.W. GERLACH, X. ZHOU, and S.F. MCCLANAHAN, The Procter & Gamble Company, Mason, OH, USA |
| 0032 |
2:15 PM | Six-month Continuous Use of Two At-home Professional Bleaching Systems on Tetracycline Stain
G. KUGEL1, A. ABOUSHALA1, X. ZHOU2, and R.W. GERLACH2, 1 Tufts University School of Dental Medicine, Boston, MA, USA, 2 The Procter & Gamble Company, Mason, OH, USA |
| 0033 |
2:30 PM | Clinical Trial of Two 6% Hydrogen Peroxide Equivalent Whitening Systems: Strips Versus Paint-On
R.W. GERLACH, X. ZHOU, and P.A. SAGEL, The Procter & Gamble Company, Mason, OH, USA |
| 0034 |
2:45 PM | Meta-analysis of the Clinical Effectiveness and Tolerability of Direct-to-Consumer Vital Bleaching Products
R.W. GERLACH, and M.L. BARKER, The Procter & Gamble Company, Mason, OH, USA |
| 0035 |
3:00 PM | 2-year Clinical Performance of 6 Direct Class 2 Resins
D.K. HEIN, J.M. TOLLEY, R.S. WAGSTAFF, and R.P. CHRISTENSEN, Clinical Research Associates, Provo, UT, USA |
| 0036 |
3:15 PM | 4-year Wear and Clinical Performance of Packable Posterior Composite
S.C. BAYNE1, A.D. WILDER, Jr.1, J. PERDIGÃO2, H.O. HEYMANN1, and E.J. SWIFT1, 1 University of North Carolina, Chapel Hill, USA, 2 University of Minnesota, Minneapolis, USA |
| 0037 |
3:30 PM | The Short-term Clinical Evaluation of Resin-modified Glass-ionomer Luting Cement, FujiCEM
S. YONEDA, T. YAMADA, J. SUGIZAKI, and M. MORIGAMI, Tranomon Hospital Dental Clinic, Tokyo, Japan |
| |
3:45 PM | Discussion |
|